TRANSARTERIAL EMBOLIZATION CONGENITAL RENAL ARTERIOVENOUS MALFORMATION AT HANOI MEDICAL UNIVERSITY HOSPITAL

Thái Bình Nguyễn, Xuân Toàn Nguyễn, Quốc Hoà Trần

Main Article Content

Abstract

Objective: To evaluate the effectiveness and safety of transarterial embolization (TAE) of congenital renal arteriovenous malformations (AVMs) using histoacryl and/or VXKL. Materials and Methods: A cross-sectional descriptive study on 11 patients with congenital renal AVMs were treated using histoacryl and/or VXKL via transarterial access was investigated for clinical presentation, imagine features, treatment methods and complications in Hanoi Medical University Hospital between February 2020 and May 2024. Results: 11 patients (5 women and 6 men; mean age, 50.6 y) with 8/11 gross hematuria, and 4/11 flank pain. Among the 11 patients, 8/11 AVMs had high-flow lesions. TAE was performed with histoacryl in 3 patients, VXKL with histoacryl in 7 patients, and VXKL in 1 patient. Technical success rate was 91% (10/11), and clinical success rate was 100% (11/11). Of the 11 patients treated, the infarcted renal areas were 2.1%–20.4% (mean, 9.8%). No complications were observed post-intervention. Renal function was normal in all patients pre - embolization and post – embolization. Conclusions: Embolization of congenital renal AVMs via transarterial approaches using histoacryl and/or VXKL was safe and effective and elicited good outcomes.

Article Details

References

1. Hatzidakis A, Rossi M, Mamoulakis C, et al. Management of renal arteriovenous malformations: A pictorial review. Insights into Imaging. 2014;5(4):523. doi:10.1007/s13244-014-0342-4
2. Hwang JH, Do YS, Park KB, Chung HH, Park HS, Hyun D. Embolization of Congenital Renal Arteriovenous Malformations Using Ethanol and Coil Depending on Angiographic Types. Journal of Vascular and Interventional Radiology. 2017;28(1):64-70. doi:10.1016/j.jvir.2016.09.004
3. Crotty KL, Orihuela E, Warren MM. Recent advances in the diagnosis and treatment of renal arteriovenous malformations and fistulas. J Urol. 1993;150(5 Pt 1):1355-1359. doi:10.1016/s0022-5347(17)35778-6
4. TAKEBAYASHI S, HOSAKA M, KUBOTA Y, ISHIZUKA E, IWASAKI A, MATSUBARA S. transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup. The Journal of Urology. Published online March 1998. doi:10.1016/S0022-5347(01)63703-0
5. Somani BK, Nabi G, Thorpe P, Hussey J, McClinton S. Therapeutic Transarterial Embolisation in the management of benign and malignant renal conditions. The Surgeon. 2006; 4(6): 348-352. doi:10.1016/S1479-666X (06)80110-1
6. Sountoulides P, Zachos I, Paschalidis K, et al. Massive hematuria due to a congenital renal arteriovenous malformation mimicking a renal pelvis tumor: a case report. J Med Case Rep. 2008;2:144. doi:10.1186/1752-1947-2-144
7. Gandhi SP, Patel K, Pandya V, Raval M. Renal arteriovenous malformation presenting with massive hematuria. Radiol Case Rep. 2015;10(1):1068. doi:10.2484/rcr.v10i1.1068
8. Mori T, Sugimoto K, Taniguchi T, et al. Renal arteriovenous fistula with rapid blood flow successfully treated by transcatheter arterial embolization: application of interlocking detachable coil as coil anchor. Cardiovasc Intervent Radiol. 2004;27(4):374-376. doi:10.1007/s00270-004-0068-7
9. Maruno M, Kiyosue H, Tanoue S, et al. Renal Arteriovenous Shunts: Clinical Features, Imaging Appearance, and Transcatheter Embolization Based on Angioarchitecture. Radiographics. 2016;36(2):580-595. doi:10.1148/rg.2016150124
10. Davidson GS, Terbrugge KG. Histologic long-term follow-up after embolization with polyvinyl alcohol particles. AJNR Am J Neuroradiol. 1995;16(4 Suppl):843-846.